FDA approves Roche’s ENSPRYNG for neuromyelitis optica spectrum disorder
It is the first and only approved therapy for NMOSD designed to target and inhibit interleukin-6 receptor activity, using novel recycling antibody technology
It is the first and only approved therapy for NMOSD designed to target and inhibit interleukin-6 receptor activity, using novel recycling antibody technology
The AccuPlex SARS-CoV-2 molecular controls kit is designed to measure day-to-day assay performance and contains positive materials
The test outperforms other molecular tests with a low detection limit of 15 GEC/reaction (250 GEC/ml of sample) and a robust control system
The consortium aims to determine the dynamics, function and potential for therapeutic intervention of the RNA and protein structures of SARS-CoV-2
IgM assay has 95.51% positive predictive value even when disease incidence is only 3%
The new assays are designed to enable turnaround times for next-generation sequencing results of less than 24 hours
Used to empower clinicians to quickly prescribe treatment regimens for multidrug-resistant TB, the test could help fill a critical gap that is jeopardizing global TB targets
Connecting the scientific community with two new online content-packed events
AnteoTech Ltd has successfully developed proof-of-concept COVID-19 antigen and Flu A&B point-of-care lateral flow tests that can detect the presence of SARS-Cov-2 and influenza in less than 15 minutes
Join this webinar, back due to popular demand, to learn all you need to know about 3D tumor modeling
Catch up on this expert webinar to learn how to improve throughput and result quality in PCR and qPCR workflows
Leveraging GenMark’s eSensor XT-8 platform hopes to expand COVID-19 diagnostic testing capacity
Bespoke custom contract service offers rapid access to broad range of high-quality antigen panels for influenza A and B viruses
We speak to a scientist at the forefront of innovative efforts to scale up coronavirus testing for use at the population level
Watch this on-demand webinar to learn all about the new alternative to live virus neutralization and immunoglobulin detection
Companion diagnostic will leverage the Oncomine Precision Assay to identify non-small cell lung cancer patients who may benefit from pyrotinib
Multi-regional strategic initiatives agreement designed to improve efficiency in care delivery, reduce cost, and enhance experience for health care consumers and providers
Enables labs to quickly ramp up testing capacity and generate results faster
Foundation for future commercial supply of CG01 secured with delivery of three master cell banks
Want to maximise the efficiency of water preparation in your lab and meet high standards at a reduced cost? All is revealed in this upcoming webinar
Join us on Thursday, September 10, to learn how the Mosquito HV liquid handler can help in obtaining single-cell RNA data